New drug EB-1020 put to the test: will it be the next 'High'?
NCT ID NCT02144415
First seen Apr 21, 2026 · Last updated Apr 30, 2026 · Updated 1 time
Summary
This study looked at whether a new drug called EB-1020 could be abused like other stimulants. 80 healthy adults who use stimulants recreationally took single doses of EB-1020, a placebo (fake drug), or d-amphetamine (a known stimulant) and rated how much they liked the effects. The goal was to see if EB-1020 produces a 'high' similar to other stimulants, which would indicate abuse potential.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY VOLUNTEERS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Vince and Associates Clinical Research, Inc.
Overland Park, Kansas, 66212, United States
Conditions
Explore the condition pages connected to this study.